MoneyWorks4Me

Zydus Lifesciences informs about press release

31 Jul 2024 Evaluate
Zydus Lifesciences has enclosed a copy of press release dated July 31, 2024 titled ‘Zydus receives approval from COFEPRIS of Mexico to market Mamitra (Trastuzumab biosimilar) to treat various cancers’. The contents of the press release give full details. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1745.80
Dr. Reddys Labs. 1233.00
Cipla 1330.80
Lupin 1949.50
Zydus Lifesciences 1117.55
View more..